Fatal Epstein-Barr virus primo infection in a 25-year-old man treated with azathioprine for Crohn's disease

Journal of Clinical Microbiology

Volumn 47, Issue 4, 2009, Pages 1252-1254

  N'guyen, Y ^a   Andreoletti, L ^a   Patey, M ^a   Lecoq Lafon, C ^a   Cornillet, P ^b   Leon A ^a   Jaussaud, R ^a   Fieschi, C ^c   Strady, C ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b HÔPITAL MAISON BLANCHE   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB; VINCRISTINE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CROHN DISEASE; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; FATALITY; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS MONONUCLEOSIS; LIVER FUNCTION TEST; LYMPHOPROLIFERATIVE DISEASE; MALE; PANCYTOPENIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VIRUS INFECTION; VIRUS LOAD;

HUMAN HERPESVIRUS 4;

ADULT; AZATHIOPRINE; CROHN DISEASE; EPSTEIN-BARR VIRUS INFECTIONS; FATAL OUTCOME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE;

EID: 65249137592     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02052-08     Document Type: Article

References (17)

1. Aubin, J., F. Davi, F. Nguyen-Salomon, D. Leboeuf, C. Debert, M. Taher, F. Valensi, D. Canioni, N. Brousse, and B. Varet. 1995. Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia 9:471-479.
2. Chan, J. K. 2001. The new World Health Organization classification of lymphomas: the past, the present and the future. Hematol. Oncol. 19:129150.
3. Dayharsh, G. A., E. V. Loftus, Jr., W. J. Sandborn, W. J. Tremaine, A. R. Zinsmeister, T. E. Witzig, W. R. Macon, and L. J. Burgart. 2002. EpsteinBarr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. Gastroenterology 122:72-77.
4. Farrell, R. J., Y. Ang, P. Kileen, D. S. O'Briain, D. Kelleher, P. W. Keeling, and D. G. Weir. 2000. Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. Gut 47:514-519.
5. Garrido Serrano, A., F. Pérez Martín, F. J. Guerrero Igea, J. Galbarro Muñoz, and S. Palomo Gil. 2000. Fatal infectious mononucleosis during azathioprine treatment in Crohn's disease. Gastroenterol. Hepatol. 23:7-8. (In Spanish.)
6. Hügle, B., I. Astigarraga, J. I. Henter, A. Porwit-MacDonald, A. Meindl, and V. Schuster. 2007. Simultaneous manifestation of fulminant infectious mononucleosis with haemophagocytic syndrome and B-cell lymphoma in X-linked lymphoproliferative disease. Eur. J. Pediatr. 166:589-593.
7. Imashuku, S. 2002. Clinical features and treatment strategies of EpsteinBarr virus-associated hemophagocytic lymphohistiocytosis. Crit. Rev. Oncol. Hematol. 44:259-272.
8. Juffermans, N. P., A. Jager, M. J. Kersten, van M. H. Oers, and D. W. Hommes. 2005. Epstein-Barr virus-related lymphomas in patients with inflammatory bowel disease. Ned. Tijdschr. Geneeskd. 149:1859-1863.
9. Kandiel, A., A. G. Fraser, B. I. Korelitz, C. Brensinger, and J. D. Lewis. 2005. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 54:1121-1125.
10. Kobbervig, C., D. Norback, and B. Kahl. 2003. Infectious mononucleosis progressing to fatal malignant lymphoma: a case report and review of the literature. Leuk. Lymphoma 44:1215-1221.
11. Larvol, L., J. C. Soule, and A. Le Tourneau. 1994. Reversible lymphoma in the setting of azathioprine therapy for Crohn's disease. N. Engl. J. Med. 331:883-884.
12. Lewis, J. D., W. B. Bilker, C. Brensinger, J. J. Deren, D. J. Vaughn, and B. L. Strom. 2001. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 121:1080-1087.
13. Losco, A., U. Gianelli, B. Cassani, L. Baldini, D. Conte, and G. Basilisco. 2004. Epstein-Barr virus-associated lymphoma in Crohn's disease. Inflamm. Bowel Dis. 10:425-429.
14. Meijer, E., and J. J. Cornelissen. 2008. Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients. Curr. Opin. Hematol. 15:576-585.
15. Posthuma, E. F., R. G. Westendorp, A. van der Sluys Veer, J. C. KluinNelemans, P. M. Kluin, and C. B. H. W. Lamers. 1995. Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine. Gut 36:311-313.
16. van Laar, J. A., C. M. Buysse, A. C. Vossen, B. Hjálmarsson, B. Van Den Berg, K. Van Lom, and J. Deinum. 2002. Epstein-Barr viral load assessment in immunocompetent patients with fulminant infectious mononucleosis. Arch. Intern. Med. 162:837-839.
17. Yamada, M., S. Hudson, O. Tournay, S. Bittenbender, S. S. Shane, B. Lange, Y. Tsujimoto, A. J. Caton, and G. Rovera. 1989. Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III) -specific probes. Proc. Natl. Acad. Sci. USA 86:5123-5127.